Safety of tocilizumab in COVID‐19 pregnant women and their newborn: A retrospective study-Reference-Cited by-同舟云学术

Safety of tocilizumab in COVID‐19 pregnant women and their newborn: A retrospective study

Published:2021-02-26 Issue:4 Volume:46 Page:1062-1070
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Jiménez‐Lozano Inés¹^ORCID,Caro‐Teller José Manuel²,Fernández‐Hidalgo Nuria³,Miarons Marta¹^ORCID,Frick Marie Antoinette³,Batllori Badia Emma⁴,Serrano Berta⁵,Parramon‐Teixidó Carlos Javier¹^ORCID,Camba‐Longueira Fátima⁶,Moral‐Pumarega Maria Teresa⁴,San Juan‐Garrido Rafael⁷,Cabañas Poy Maria Josep¹,Suy Anna⁵,Gorgas Torner Maria Queralt¹

Affiliation:

1. Pharmacy Department Vall d’Hebron Hospital Universitari Vall d’Hebron Barcelona Hospital Campus Barcelona Spain

2. Pharmacy Department. Hospital Universitario "12 de Octubre" Research Institute 12 de Octubre (i+12 Madrid Spain

3. Pediatric Infectious Diseases and Primary Immunodeficiencies Unit Pediatrics Department Vall d´hebron Hospital Barcelona Spain

4. Unit of perinatal medicine, Obstetric and Gynaecology Department Hospital Universitario "12 de Octubre" Research Institute 12 de Octubre (i+12 Madrid Spain

5. Department of Obstetrics and Gynecology Vall d’Hebron Hospital Universitari Vall d’Hebron Barcelona Hospital Campus Barcelona Spain

6. Department of Neonatology Vall d’Hebron Hospital Universitari Vall d’Hebron Barcelona Hospital Campus Barcelona Spain

7. Unit of Infectious Diseases Hospital Universitario "12 de Octubre" Research Institute 12 de Octubre (i+12 Madrid Spain

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13394

Reference39 articles.

1. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know

2. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020

3. Maternal and perinatal outcomes with COVID‐19: A systematic review of 108 pregnancies

4. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome

5. Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study;The Lancet Rheumatology;2024-09

2. Inflammatory mechanisms of preterm labor and emerging anti-inflammatory interventions;Cytokine & Growth Factor Reviews;2024-08

3. COVID-19 therapeutics for the pregnant patient;Seminars in Perinatology;2024-06

4. COVID-19 Infection in Obstetrical Patients Requiring Intensive Care: An Update;Updates in Intensive Care of OBGY Patients;2024

5. Clinical course and management of COVID-19 in the era of widespread population immunity;Nature Reviews Microbiology;2023-12-19